NCT00476008View on ClinicalTrials.gov

Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Alzheimer's Disease
Interventions
DRUG

Memantine

One tablet memantine (Namenda)10mg morning and evening (BID) for 12 months

DRUG

Placebo

One tablet placebo morning and evening (BID) for 12 months

Trial Locations (1)

33431

Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Florida Atlantic University

OTHER